APIX Biosciences
The computed 12-month bankruptcy probability of APIX Biosciences is 1.0% (low). The 2025 annual accounts show equity of €1.08M and a net result of €-621k. Equity is shrinking by ~4.5% per year across the filed fiscal years. Its solvency ranks better than 30% of 81 sector peers (fiscal year 2025). The company has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €1.08M |
| Net result | €-621k |
| Staff (FTE) | 4 |
| Better than sector | 30% |
Fragile profile, watch profitability in particular.
All 5 axes are computed from data Checked has read.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit from Kantoor S.
See plans →How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 18.3% | 49.8% | |
| Net result | €-621k | €17k | |
| Equity | €1.08M | €102k | |
| Gross operating margin | €-149k | €49k | |
| Total assets | €5.89M | €250k |
| Fiscal year | 2025 |
|---|---|
| Deposit | verkort |
| Revenue | - |
| EBITDA | €-578k |
| Net profit | €-621k |
| Cash flow | €-519k |
| Staff costs | €428k |
| Income taxes | €-60k |
| Dividends | - |
| Total assets | €5.89M |
| Equity | €1.08M |
| Debt | €4.82M |
| of which ≤ 1y | €294k |
| of which > 1y | €4.50M |
| Working capital | €403k |
| Employees (FTE) | 4.0 |
| 2025 | |
|---|---|
| Current ratio | 2.37 |
| Quick ratio | 2.37 |
| Working capital ratio | 6.8% |
| Solvency | 18.3% |
| Debt / equity | 4.47 |
| Long-term debt ratio | 4.18 |
| Interest coverage | -45.88 |
| Gross margin | - |
| Net margin | - |
| ROA | -10.5% |
| ROE | -57.7% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2025 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €5.89M |
| Fixed assets | 21/28 | €5.13M |
| Formation expenses | 20 | €63k |
| Intangible fixed assets | 21 | €4.67M |
| Tangible fixed assets | 22/27 | €302k |
| Financial fixed assets | 28 | €161k |
| Current assets | 29/58 | €698k |
| Amounts receivable within one year | 40/41 | €263k |
| Investments | 50/53 | €0 |
| Cash & bank | 54/58 | €430k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €5.89M |
| Equity | 10/15 | €1.08M |
| Contributions / capital | 10/11 | €1.91M |
| Accumulated profits (losses) | 14 | €-829k |
| Amounts payable | 17/49 | €4.82M |
| Amounts payable after one year | 17 | €4.50M |
| Amounts payable within one year | 42/48 | €294k |
| Trade debts payable within one year | 44 | €225k |
| Income statement | ||
| Gross operating margin | 9900 | €-149k |
| Operating result | 9901 | €-681k |
| Financial income | 75 | €13k |
| Financial charges | 65 | €13k |
| Result before taxes | 9903 | €-680k |
| Income taxes | 67/77 | €-60k |
| Net result for the period | 9904 | €-621k |
| Result to be appropriated | 9905 | €-621k |
-
DE LIERLegal entityDirector· perm. rep.: François van LierdeState Gazette act 25147485 (20-11-2025)Current28-08-2025 → present
-
Current28-08-2025 → present
-
Current19-06-2025 → present
-
Current21-06-2022 → present
2 events
- 21-06-2022 Appointed· Director
- 21-06-2022 Appointed· Managing director
Former directors (5)
-
Former19-12-2023 → 25-08-2025
2 events
- 25-08-2025 Resigned· Director
- 19-12-2023 Appointed· Director
-
Former- → 25-08-2025
-
Former- → 19-06-2025
-
Former- → 24-11-2023
-
Former- → 21-06-2022
2 events
- 21-06-2022 Resigned· Director
- 21-06-2022 Resigned· Managing director
| NACE primary | Speur- en ontwikkelingswerk op biotechnologisch gebied(72101) |
| Legal form | Public limited company(014) |
| Incorporation | 23-07-2021 |
| Status | Active |
| Postal code | 8750 |
Each band states what its claims rest on. A board seat is influence over the board, not ownership. Court mandates (receiver, interim administrator) and liquidation mandates do not link companies and are therefore absent here; they belong under Directors & mandates.
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 37018C0214/00S002 | Flanders | 2,274 m² | 1 · 2,877 m² | - |
| 37018D0409/00R000 | Flanders | 2,204 m² | 1 · 140 m² | 7.4 m · 2 fl. |
| 37018D0016/00H002 | Flanders | 644 m² | 1 · 362 m² | 12.7 m · 2 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
27-11-2025 Publication in the Belgian Official Gazette, Miscellaneous
Technical details
{
"notary": {
"name": "Benedikt DEBERDT",
"firm_city": null,
"firm_name": "Notaris Benedikt DEBERDT",
"office_city": "Tielt",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2025-11-27",
"filing_date": "2025-11-25",
"act_kind_objet": "DIVERSEN"
},
"key_dates": [
{
"date": "2025-10-29",
"label": "akte date"
},
{
"date": "2025-11-05",
"label": "Registratierechten"
},
{
"date": "2025-11-27",
"label": "Bijlagen bij het Belgisch Staatsblad"
},
{
"date": "2025-11-25",
"label": "Neergelegd"
}
],
"key_parties": [
{
"kbo": "0771667563",
"kind": "org",
"name": "APIX Biosciences",
"role": "Aandeelhouder"
},
{
"kind": "person",
"name": "Notaris Benedikt DEBERDT",
"role": "Notaris"
},
{
"kind": "org",
"name": "Raad van Bestuur",
"role": "Bestuurder"
}
],
"key_amounts_eur": [
{
"label": "Ontvangen registratierechten",
"amount": 50.0
}
],
"subject_company": {
"kbo": "0771.667.563",
"name_full": "APIX Biosciences",
"legal_form": "Naamloze vennootschap"
},
"publication_proxy": {
"kind": null
},
"summary_narrative": "",
"co_filed_documents": [],
"detected_real_type": "statutes_change"
}20-11-2025 2 directors appointed, 2 resigning
- François van Lierde, Bestuurder
- Maarten Duyck, Bestuurder
- Jeremy Barnes, Bestuurder
- Tina Rogge, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Jeremy Barnes",
"address": null,
"birth_date": null
},
"effective_date": "2025-08-25",
"evidence_quote": "Het vrijwillig ontslag van de heer Jeremy Barnes, wonende te Erinvore, Torrisdale, Campbeltown, Argyll PA28 QT, Schotland, als bestuurder met ingang van 25/08/2025"
},
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Tina Rogge",
"address": null,
"birth_date": null
},
"effective_date": "2025-08-25",
"evidence_quote": "het vrijwillig ontslag van mevrouw Tina Rogge, wonende te Sint Barbarastraat 30, 9990 Maldegem, Belgi\u00EB, als bestuurder met ingang van 25/08/2025."
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Fran\u00E7ois van Lierde",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0776975839",
"name": "BV DE LIER",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2025-08-28",
"evidence_quote": "BV DE LIER, een besloten vennootschap naar Belgisch recht, met zetel te 8300 Knokke-Heist, Koningin Fabiolalaan 9 bus 11 en ingeschreven in de Kruispuntbank voor Ondernemingen onder het nummer 0776.975.839, vast vertegenwoordigd door de heer Fran\u00E7ois van Lierde"
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Maarten Duyck",
"address": null,
"birth_date": null
},
"effective_date": "2025-08-28",
"evidence_quote": "de heer Maarten Duyck, geboren te Jette op 20 december 1993, ingeschreven in het Rijksregister onder nummer 93.12.20-529.35, woonachtig te 1050 Elsene, Gewijde-Boomstraat 87."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0771.667.563",
"name_full": "APIX BIOSCIENCES",
"legal_form": "NV"
}
}18-07-2025 1 director appointed, 1 resigning
- BOGAERT Thierry, Bestuurder
- BOGAERT Thierry, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "BOGAERT Thierry",
"address": null,
"birth_date": null
},
"effective_date": "2025-06-19",
"evidence_quote": "De vergadering besluit tot het ontslag als bestuurder van de heer BOGAERT Thierry, voornoemd, en dit met ingang vanaf heden. Kwijting wordt hem verleend op de eerstvolgende algemene vergadering."
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "BOGAERT Thierry",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0771404277",
"name": "Mellona",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2025-06-19",
"evidence_quote": "Wordt aangesteld als bestuurder en dit met ingang vanaf heden, \u201CMellona\u201D, maatschap voornoemd, vast vertegenwoordigd door de heer BOGAERT Thierry, voornoemd, die zijn mandaat heeft aanvaard, en dit tot en met 22 juli 2027."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0771.667.563",
"name_full": "APIX BIOSCIENCES",
"legal_form": "NV"
}
}17-06-2025 Capital increase of €2,500,000 to €5,406,044.43
- €2.906.044,43 → €5.406.044,43
- 4 kapitaalbewegingen in deze akte
Technical details
{
"events": [
{
"kind": "capital_increase",
"amount": 1000114.9,
"currency": "EUR",
"after_eur": 2906044.43,
"delta_eur": 1000114.9,
"before_eur": 1905929.53,
"amount_type": "kapitaal_effectief",
"effective_date": "2025-05-23",
"evidence_quote": "Ingevolgde de huidige uitoefening van inschrijvingsrechten wordt het kapitaal van de voormelde vennootschap \u201CAPIX Biosciences\u201D verhoogd met een bedrag van 1.000.114,90 EUR, gepaard gaande met een uitgifte van 10.344 Preferente Aandelen en 1.149 Aandelen B, die allen volledig zijn volgestort, ten bewijze waarvan een attest werd overhandigd uitgaande van ING bank de dato 23 mei 2025. Zodoende wordt het kapitaal van de vennootschap gebracht van 1.905.929,53 EUR op 2.906.044,43 EUR",
"contribution_type": "in_kind"
},
{
"kind": "capital_increase",
"amount": 2500000.0,
"currency": "EUR",
"after_eur": 5406044.43,
"delta_eur": 2500000.0,
"before_eur": 2906044.43,
"amount_type": "kapitaal_effectief",
"effective_date": "2025-05-27",
"evidence_quote": "De vergadering beslist vervolgens een kapitaalverhoging door te voeren ten bedrage van 2.500.000,00 EUR om het kapitaal te brengen van 2.906.044,43 EUR op 5.406.044,43 EUR door de in onderhavige akte beschreven inbreng in natura (schuldvordering onder de vorm van een converteerbare lening de dato 19 december 2023)... De vergadering stelt vast en verzoekt ons, notaris, akte te nemen van het feit dat de voormelde kapitaalverhoging van 2.500.000,00 EUR daadwerkelijk verwezenlijkt werd en dat het kapitaal aldus daadwerkelijk gebracht werd van 2.906.044,43 EUR op 5.406.044,43 EUR",
"contribution_type": "in_kind"
},
{
"kind": "capital_increase",
"amount": 21235.2,
"currency": "EUR",
"after_eur": 5427279.63,
"delta_eur": 21235.2,
"before_eur": 5406044.43,
"amount_type": "kapitaal_effectief",
"effective_date": "2025-05-23",
"evidence_quote": "Ingevolgde de huidige uitoefening van inschrijvingsrechten wordt het kapitaal van de voormelde vennootschap \u201CAPIX Biosciences\u201D verhoogd met een bedrag van 21.235,20 EUR, gepaard gaande met een uitgifte van 316 Aandelen B, die allen volledig zijn volgestort, ten bewijze waarvan een attest werd overhandigd uitgaande van ING bank de dato 23 mei 2025... Zodoende wordt het kapitaal van de vennootschap gebracht van 5.406.044,43 EUR op 5.427.279,63 EUR",
"contribution_type": "cash"
},
{
"kind": "capital_increase",
"amount": 1000000.0,
"currency": "EUR",
"after_eur": 6427279.63,
"delta_eur": 1000000.0,
"before_eur": 5427279.63,
"amount_type": "kapitaal_effectief",
"effective_date": "2025-05-27",
"evidence_quote": "De vergadering beslist vervolgens een kapitaalverhoging door te voeren ten bedrage van 1.000.000,00 EUR om het kapitaal te brengen van 5.427.279,63 EUR op 6.427.279,63 EUR door de in onderhavige akte beschreven inbreng in natura (schuldvordering onder de vorm van een converteerbare lening de dato 3 februari 2025)... De vergadering stelt vast en verzoekt ons, notaris, akte te nemen van het feit dat de voormelde kapitaalverhoging van 1.000.000,00 EUR daadwerkelijk verwezenlijkt werd en dat het kapitaal aldus daadwerkelijk gebracht werd van 5.427.279,63 EUR op 6.427.279,63 EUR",
"contribution_type": "in_kind"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0771.667.563",
"name_full": "APIX BIOSCIENCES",
"legal_form": "NV"
}
}09-04-2024 1 director appointed, 1 resigning
- Jeremy Barnes, Bestuurder
- Geraldine Wright, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Geraldine Wright",
"address": null,
"birth_date": null
},
"effective_date": "2023-11-24",
"evidence_quote": "Het vrijwillig ontslag van mevrouw Geraldine Wright, wonende te 35 Henley Street, Oxford OX1 3SZ, UK, als bestuurder met ingang van 24/11/2023."
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Jeremy Barnes",
"address": null,
"birth_date": null
},
"effective_date": "2023-12-19",
"evidence_quote": "De aandeelhouders besluiten met meerderheid van stemmen om, de hiernavolgende persoon te benoemen tot bestuurder van de vennootschap, met ingang van 19 december 2023 en dit tot 22 juli 2027: - de heer Jeremy Barnes, wonende te Erinvore, Torrisdale, Campbeltown, Argyll PA28 QT, Schotland."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0771.667.563",
"name_full": "APIX BIOSCIENCES",
"legal_form": "NV"
}
}23-01-2024 Articles of association amended
Technical details
{
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"statute_change": {
"name_change": false,
"seat_change": false,
"object_change": false,
"effective_date": "2023-12-18",
"legal_form_change": false
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0771.667.563",
"name_full": "APIX BIOSCIENCES",
"legal_form": "NV"
},
"signature_regime": null,
"special_mandates": [],
"governance_change": {
"admin_delegated_added": []
}
}07-09-2022 Capital increase of €700,115.80 to €1,905,929.53
- €1.205.813,73 → €1.905.929,53
Technical details
{
"events": [
{
"kind": "capital_increase",
"amount": 700115.8,
"currency": "EUR",
"after_eur": 1905929.53,
"delta_eur": 700115.8,
"before_eur": 1205813.73,
"amount_type": "kapitaal_effectief",
"effective_date": "2022-08-23",
"evidence_quote": "KAPITAALVERHOGING Ingevolgde de huidige uitoefening van inschrijvingsrechten wordt het kapitaal van de voormelde vennootschap \u201CAPIX Biosciences\u201D verhoogd met een bedrag van zevenhonderdduizend honderdvijftien euro tachtig cent (700.115,80 EUR) ... Het kapitaal bedraagt \u00E9\u00E9n miljoen negenhonderdenvijfduizend negenhonderdnegenentwintig euro drie\u00EBnvijftig cent (1.905.929,53 EUR).",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0771.667.563",
"name_full": "APIX BIOSCIENCES",
"legal_form": "NV"
}
}21-06-2022 2 directors appointed, 2 resigning
- Jan Bogaert, Bestuurder
- Jan Bogaert, Gedelegeerd bestuurder
- Jan Bogaert, Bestuurder
- Jan Bogaert, Gedelegeerd bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Jan Bogaert",
"address": null,
"birth_date": null
},
"effective_date": "2022-06-21",
"evidence_quote": "De aandeelhouders besluiten unaniem om, met ingang vanaf de datum van onderhavige schriftelijke besluiten, het mandaat van de hiernavolgende bestuurder te herroepen: - de heer Jan Bogaert, met woonplaats te 8750 Wingene, Blauwhuisstraat 11."
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Jan Bogaert",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0773713570",
"name": "BV Myrmex",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2022-06-21",
"evidence_quote": "De aandeelhouders besluiten unaniem om, met ingang vanaf de datum van onderhavige schriftelijke besluiten tot 22 juli 2027, de hiernavolgende persoon te benoemen tot bestuurder van de vennootschap: - BV Myrmex, een besloten vennootschap naar Belgisch recht, met maatschappelijk zetel te 8750 Wingene,"
},
{
"kind": "director_out",
"role": "gedelegeerd_bestuurder",
"person": {
"rrn": null,
"name": "Jan Bogaert",
"address": null,
"birth_date": null
},
"effective_date": "2022-06-21",
"evidence_quote": "De raad van bestuur besluit met unanimiteit om, met ingang vanaf de datum van onderhavige schriftelijke besluiten, het mandaat van de hiernavolgende gedelegeerd bestuurder te herroepen: -de heer Jan Bogaert, met woonplaats te 8750 Wingene, Blauwhuisstraat 11."
},
{
"kind": "director_in",
"role": "gedelegeerd_bestuurder",
"person": {
"rrn": null,
"name": "Jan Bogaert",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0773713570",
"name": "BV Myrmex",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2022-06-21",
"evidence_quote": "De raad van bestuur besluit met unanimiteit, met ingang vanaf de datum van onderhavige schriftelijke besluiten, de hiernavolgende persoon te benoemen tot gedelegeerd bestuurder van de vennootscha\u0440: -BV MYRMEX, een besloten vennootschap naar Belgisch recht, met maatschappelijk zetel te 8750 Wingene, "
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0771.667.563",
"name_full": "APIX BIOSCIENCES",
"legal_form": "NV"
}
}01-09-2021 Capital increase of €1,144,313.73 to €1,205,813.73
- €61.500 → €1.205.813,73
Technical details
{
"events": [
{
"kind": "capital_increase",
"amount": 1144313.73,
"currency": "EUR",
"after_eur": 1205813.73,
"delta_eur": 1144313.73,
"before_eur": 61500.0,
"amount_type": "kapitaal_effectief",
"effective_date": "2021-08-18",
"evidence_quote": "De vergadering beslist een kapitaalverhoging door te voeren ten bedrage van \u00E9\u00E9n miljoen honderdvierenveertigduizend driehonderd dertien euro drie\u00EBnzeventig cent (1.144.313,73 EUR), om het kapitaal van \u00E9\u00E9nenzestigduizend vijfhonderd euro (61.500,00 EUR) te brengen op \u00E9\u00E9n miljoen tweehonderdenvijfduizend achthonderd dertien euro drie\u00EBnzeventig cent (1.205.813,73 EUR).",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0771.667.563",
"name_full": "APIX BIOSCIENCES",
"legal_form": "NV"
}
}27-07-2021 Incorporation of a new NV
Technical details
{
"kind": "oprichting",
"seat": "Blauwhuisstraat 11, 8750 Wingene",
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"founders": [
{
"org": null,
"kind": "natural_person",
"person": {
"dob": "1971-12-21",
"name": "Prof. WRIGHT Geraldine Ann",
"niss": null,
"address": "35 Henley Street, Oxford OX1 3SZ, UK"
},
"share_class": "A",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 17859.97,
"holder_person_name": "Prof. WRIGHT Geraldine Ann",
"is_subscriber_only": false,
"n_shares_subscribed": 800,
"amount_subscribed_eur": 17859.97,
"is_anonymous_silent_partner": false
},
{
"org": null,
"kind": "natural_person",
"person": {
"dob": "1962-04-08",
"name": "Prof. SHAFIR Sharon Iechiel",
"niss": null,
"address": "70A Kazenelson Street, Nes Ziona, 7403950, Isra\u00EBl"
},
"share_class": "A",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 16632.09,
"holder_person_name": "Prof. SHAFIR Sharon Iechiel",
"is_subscriber_only": false,
"n_shares_subscribed": 745,
"amount_subscribed_eur": 16632.09,
"is_anonymous_silent_partner": false
},
{
"org": null,
"kind": "natural_person",
"person": {
"dob": "1960-05-27",
"name": "Prof. BARNES Jeremy David",
"niss": null,
"address": "Erinvore, Torrisdale, Campbeltown, Argyll PA28 6QT, Schotland"
},
"share_class": "A",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 17859.97,
"holder_person_name": "Prof. BARNES Jeremy David",
"is_subscriber_only": false,
"n_shares_subscribed": 800,
"amount_subscribed_eur": 17859.97,
"is_anonymous_silent_partner": false
},
{
"org": null,
"kind": "natural_person",
"person": {
"dob": "1989-01-05",
"name": "Dr. STABLER Daniel",
"niss": null,
"address": "3 Pipley Furlong, Oxford, OX4 4JW, UK"
},
"share_class": "A",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 2678.99,
"holder_person_name": "Dr. STABLER Daniel",
"is_subscriber_only": false,
"n_shares_subscribed": 120,
"amount_subscribed_eur": 2678.99,
"is_anonymous_silent_partner": false
},
{
"org": null,
"kind": "natural_person",
"person": {
"dob": "1986-08-15",
"name": "Dr. TEIXEIRA DE SOUSA Raquel",
"niss": null,
"address": "345 Marston Road OX3 OEP, Oxford, UK"
},
"share_class": "A",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 2678.99,
"holder_person_name": "Dr. TEIXEIRA DE SOUSA Raquel",
"is_subscriber_only": false,
"n_shares_subscribed": 120,
"amount_subscribed_eur": 2678.99,
"is_anonymous_silent_partner": false
},
{
"org": null,
"kind": "natural_person",
"person": {
"dob": "1986-12-08",
"name": "De heer DA SILVA GON\u00C7ALVES Rui Fernando",
"niss": null,
"address": "345 Marston Road OX3 OEP, Oxford, UK"
},
"share_class": "A",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 2678.99,
"holder_person_name": "De heer DA SILVA GON\u00C7ALVES Rui Fernando",
"is_subscriber_only": true,
"n_shares_subscribed": 120,
"amount_subscribed_eur": 2678.99,
"is_anonymous_silent_partner": false
},
{
"org": null,
"kind": "natural_person",
"person": {
"dob": "1992-05-18",
"name": "De heer BOGAERT Jan David",
"niss": null,
"address": "Blauwhuisstraat 11, 8750 Wingene, Belgi\u00EB"
},
"share_class": "B",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 1111.0,
"holder_person_name": "De heer BOGAERT Jan David",
"is_subscriber_only": true,
"n_shares_subscribed": 1111,
"amount_subscribed_eur": 1111.0,
"is_anonymous_silent_partner": false
}
],
"capital_eur": 61500.0,
"subject_company": {
"kbo": "0771.667.563",
"name_full": "APIX Biosciences",
"legal_form": "NV"
},
"initial_directors": [],
"incorporation_date": "2021-07-22",
"post_incorporation_mandates": []
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameNL | APIX Biosciences |